Muromonab-Cd3 vs Trastuzumab
Muromonab-Cd3 vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Muromonab-Cd3 and Trastuzumab.
Mechanism of Action
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Trastuzumab — 28 days.
Chemical Properties
Type: Muromonab-Cd3 — Unknown; Trastuzumab — Antibody.